Modification of responses of Candida albicans to cisplatin by membrane damaging antimycotic agents

No Thumbnail Available
Authors
Sarachek, Alvin
Henderson, Lori A.
Issue Date
1991-03
Type
Article
Language
eng
Keywords
Research Support, Non-U.S. Gov't
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract

The genotoxic, antineoplastic platinum coordination complex, cisplatin (cis-diamminedichloroplatinum (II], exists as a positively charged aquated complex in water solution and as a neutral, nonaquated complex in saline solution. Candida albicans exhibited greater susceptibilities to cellular inactivation and induction of mitotic recombination when treated with the aquated rather than the nonaquated drug. The differential in responses was expressed by cells grown after treatment at 37 degrees C or at 25 degrees C, a temperature which promotes recovery from DNA damages by the yeast generally. Studies with protoplasts established that cell wall components do not influence cellular reactions to either form of the drug. However, membrane damaging antimycotic agents markedly affected responses. Pretreatments with fungistatic ketoconazole or with miconazole, under fungistatic or fungicidal conditions, enhanced cellular resistance to inactivation by aquated cisplatin: the effect was more pronounced with post-cisplatin growth at 25 degrees C than 37 degrees C. Fungicidal pretreatments with amphotericin B or miconazole greatly increased susceptibilities of surviving cells to the lethal and recombinagenic effects of nonaquated cisplatin with post-cisplatin recovery at 25 degrees C or 37 degrees C. Possible mechanisms underlying these responses and their implications for stability of C. albicans populations in cancer patients undergoing therapy with cisplatin are discussed.

Description
Click on the DOI link below to access the article (may not be free).
Citation
Mycoses. 1991 Mar-Apr; 34(3-4): 177-82.
Publisher
Wiley-Blackwell Verlag GmbH
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
0933-7407
EISSN